Charles River Laboratories CRL Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$182.84M-28.6% | -$142.16M— | —— | —— | —— | ||
| $350.1M-13.2% | $403.31M-5.6% | $427.14M-0.7% | $430.17M+8.4% | $396.75M+9.7% | ||
| $80.33M+13.0% | $71.08M+0.6% | $70.69M+5.9% | $66.75M+0.7% | $66.29M-5.2% | ||
| $607.03M-17.7% | $737.65M-1.6% | $749.49M-4.8% | $787.45M+1.4% | $776.39M+5.7% | ||
| $215.74M-1.6% | $219.15M+6.5% | $205.82M-1.5% | $208.96M-2.0% | $213.15M-8.5% | ||
| $405.01M— | $0— | —— | —— | —— | ||
| -$571.69M-173% | -$209.32M-8.7% | -$192.62M-6.9% | -$180.25M+12.0% | -$204.77M+16.4% | ||
| $215.83M-40.2% | $360.67M0.0% | $360.7M-21.8% | $461.39M-0.3% | $462.96M+288% | ||
| $1.72B+40.4% | $1.23B+4.4% | $1.18B-9.8% | $1.3B+8.9% | $1.2B+10.7% | ||
| $1.56B+15.3% | $1.35B+2.4% | $1.32B-5.4% | $1.39B+3.2% | $1.35B-9.6% | ||
| -$83.68M+84.4% | -$536.73M+4.3% | -$560.74M+8.9% | -$615.66M+8.7% | -$674.6M-22.4% | ||
| -$33.53M-422% | $10.43M+531% | -$2.42M— | —— | —— | ||
| $391.29M-24.5% | $518.49M-4.6% | $543.67M-6.0% | $578.5M+2.7% | $563.24M+12.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Charles River Laboratories generate?
- Charles River Laboratories (CRL) generated $607.0M in operating cash flow over the trailing twelve months.
- What is Charles River Laboratories's free cash flow?
- After $215.7M of capital expenditures, Charles River Laboratories's free cash flow was $391.3M over the trailing twelve months, down 30.5% year over year.
- Where does Charles River Laboratories's cash flow data come from?
- Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
